Survival of GBM patients between low and high m6AScore groups of different molecular subtypes was assessed using K-M analysis, which showed that the IDH-WT-m6AScore low group had the best survival advantage and the IDH-WT-m6AScore high group had the worst overall survival; among different methylation statuses, the MGMT-methylated-m6AScore low group had the highest overall survival and the MGMT-unmethylated-m6AScore high group had the worst overall survival; the m6AScore low group also had a significant survival advantage over the high group in different x1p19q code statuses (6). The gene discussed is IDH1; the disease is glioblastoma.